Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +700 | +67.55% | $0.00 | 1.74K | Apr 8, 2023 | Direct | F1, F2 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$113K | -243 | -14% | $466.24 | 1.49K | Apr 8, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -700 | -50% | $0.00 | 700 | Apr 8, 2023 | Bio-Rad A Common Stock | 700 | $0.00 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
F2 | Includes 44.9320 and 38.3360 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/30/2022 and 3/31/2023, respectively. |
F3 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
F4 | On April 8, 2019, the reporting person was granted 3,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |